DOCSLIB.ORG

Familial Hypokalaemic Periodic Paralysis in Finland

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Familial Hypokalaemic Periodic Paralysis in Finland 3223Journal of Neurology, Neurosurgery, and Psychiatry 1992;55:322-324 SHORT REPORT J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.55.4.322 on 1 April 1992. Downloaded from Familial hypokalaemic periodic paralysis in Finland I M Kantola, L T Tarssanen Abstract carried out on both asymptomatic and sympto- Seven families with familial hypokalaemic matic family members. This is a rectangular 30 periodic paralysis were found in Finland. minute, 100 W bicycle exercise test. During Nine of the 103 asymptomatic family the exercise the rise in the plasma potassium members studied had abnormal results on concentration is monitored. According to our a potassium exercise test. The overall results, a rise in concentration of < 05 mmol/ prevalence of familial hypokalaemic peri- 1 or the ratio rise in concentration: pulse rise odic paralysis in Finland was 0-41100 000. < 0 090 suggests the diagnosis of hypoka- Carbohydrate intake and hard exercise laemic periodic paralysis. were the most important triggers of paralytic attacks. Half of the patients reported having attacks at least once a Results month. Seven patients reported cardiac Seven families with familial hypokalaemic peri- symptoms (especially bradycardia) dur- odic paralysis were found in Finland. In these ing attacks. Permanent muscular weak- families 21 living (15 men and six women) and ness was not prominent. 11 dead (six men and five women) patients with certain paralytic attacks with hypokalae- mia were noted. In the seven families 171 Familial hypokalaemic periodic paralysis is a living (80 men and 91 women) and 119 dead rare disease of undetermined cause charac- (65 men and 54 women) asymptomatic adult terised by transient attacks of hypotonic paral- family members were found. Of these 171 ysis ofvarying severity, occurring at intervals of family members 103 (49 men and 54 women) days to years in otherwise healthy people. were investigated, but not the remainder for Usually there is hypokalaemia during attacks. various reasons. Nine asymptomatic family Attacks may be precipitated by glucose members (five men and four women) showed infusion, high carbohydrate meal, emotional the same low potassium rise in the exercise test excitement, and severe muscular exertion. The as seen in symptomatic family members.2 attacks usually begin at puberty and cease at Muscle biopsies were performed on four of http://jnnp.bmj.com/ the age of 50-60 years. The mode of inherit- them. Typical dilated sarcoplasmic reticulum ance is thought to be autosomal dominant. was seen in all cases. Attacks are more common in males.' Most of the patients had been born in We determined the number of families with central Finland or Savo. Members of two hypokalaemic periodic paralysis in Finland and families were born in southwest Finland. The described their characteristics. mean (SD) age at onset ofparalytic attacks was 12 (5) years (range 6-23 years). This was lower in females (6 5 (0 5) years) than in males (15 5 on September 29, 2021 by guest. Protected copyright. Patients and methods (3 5) years). The intensity of the disease The number of families with familial hypoka- seemed to vary from one family to another. laemic periodic paralysis was determined by One patient had > 9 attacks a month, three using a special questionnaire which was sent to had 4-8 a month, eight had 1-3 a month, two chief physicians in the departments of medi- had 1-2 a year, and seven had less frequent Department of Medicine, University cine and neurology in all university hospitals, attacks. Hospital, Turku, central hospitals, and district hospitals in The attacks began in the legs in five patients, Finland Finland. If no response was received hospitals the arms in two, and in both in 14. No facial or I M Kantola were personally contacted. The family mem- eye muscle paralysis was reported. Five Departnent of bers were interviewed by the investigator. The reported permanent mild muscular Medicine, Central patients Hospital, Mikkeli, families were traced as far back as the members weakness in the extremities, which did not Finland could remember. Population registers were not affect their ability to work. L T Tarssanen used. A special questionnaire to obtain infor- One patient had a permanent cardiac pace- Correspondence to: mation about the age at onset, the maker and aortic valve one other Dr Kantola, Department of patient's prosthesis; Medicine, Turku University frequency and severity of paralytic attacks, any had familial hypercholesterolemia. Physical Hospital, SF-20520 Turku, mus- examination of the other revealed no Finland. possible provocative factors, permanent patients cular and the effect of pregnancy or Received 16 March 1990 weakness, cardiovascular, endocrinological, gastro- and in revised form 29 May was given to patients with paralytic attacks. intestinal abnormalities. Tendon reflexes were 1990. examination was on all normal. Muscle was reduced to MRC Accepted 18 September Physical performed power 1991 participants. A potassium exercise test2 was grade 4 in one patient and normal in all others. Familial hypokalaemic periodic paralysis in Finland 323 Five patients experienced constipation during but the ratio seemed to vary considerably from J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.55.4.322 on 1 April 1992. Downloaded from their severest attacks. Three of them had also one family to another. In some families the difficulties in urinating. One patient had poly- gene was completely non-penetrant in women uria after the attacks. Seven reported cardiac whereas in another women were affected more symptoms (especially slow pulse rate) during than men. This variability may explain the severe attacks. Five had respiratory symptoms, variable penetrance observed in earlier stud- most of them difficulties in coughing up ies.' 4-6 Our families were concentrated mainly secretions. One patient described breathing in two districts. This concentration may be due difficulties as if the diaphragm did not move at to the fact that in the past Finnish people did all. not move much from one place to another, and A variety offactors triggered paralysis. These the families may have one common pro- included carbohydrate intake (11), hard exer- genitor. cise (eight), eating sweets and chocolate (five), The age at onset differed considerably evening meals (four), irregular meals (three), between men and women. Johnsen' did not cold (two), fatigue (two), and rainy weather find this kind of difference in Danish patients. (one). One reported an increased frequency of Four of the Finnish patients belonged to the attacks during pregnancy; another had no same family, and possibly the early beginning attacks during pregnancy but had attacks of the paralytic attacks was characteristic to nearly every night after delivery. Three patients that specific family. The frequency of paralytic had no difficulties during pregnancy and breast attacks may vary not only from one patient to feeding. another but also in each patient at different Twelve patients had used potassium, seven periods of his or her life. ' 7 In Finnish patients acetazolamide, and two dichlorphenamide as no variation in paralytic attacks was seen in medication. Eight of the 12 patients found severe forms of the disease, the patients having potassium useful as a prophylactic agent had weekly attacks during the whole of their against attacks, three patients found no differ- disease. The disease seems to be milder in ence, and one found it useful only during Finland than in Denmark because about one attacks. Acetazolamide had been useful for five third of the Finnish patients but only one tenth patients as a prophylactic agent. Two patients of the Danish patients' had had only one or who had no benefit from acetazolamide were two paralytic attacks. transferred to dichlorphenamide, and their Although many of the patients described paralytic attacks almost stopped. Four of the slow pulse rate during attacks, only one had 21 patients had not had attacks for 10-20 had life threatening bradycardia. No other years. They had had their last attack at the age cases of hypokalaemic periodic paralysis with of 21-40 years. We confirmed the inheritance ventricular arrhythmias89 were found in to be autosomal dominant. The penetrance Finland. was weak. The male preponderance was 1 -9: 1, Kramer et allo suggested that cardiomyop- varying from one family to another. athy might be a complication of hypokalaemic periodic paralysis, but we found no signs of decreased cardiovascular working capacity Discussion during the exercise test. According to our results the prevalence of The factors eliciting paralysis were similar in http://jnnp.bmj.com/ familial hypokalaemic periodic paralysis in both Finnish and Danish patients.4 Patients Finland is 0-4/100 000. Possibly as knowledge should be warned against taking large of the disease increases so will the prevalence, carbohydrate-rich meals before going to bed. as was seen from the Danish numbers. The Also hard exercise and cold, rainy weather prevalence in Denmark was calculated as seem to precipitate attacks. No regular changes 0-8/100 000 in 1959 by Sagild3 and in the pattern of attacks were seen during 1*25/10 000 in 1978 byJohnsen.'We probably pregnancy or breast feeding. There is no reason found almost all known Finnish patients to advise against pregnancy for women with on September 29, 2021 by guest. Protected copyright. because the hospitals where the questionnaire familial hypokalaemic periodic paralysis. was sent should know all patients with this kind Almost half of our patients had used potas- of rare diagnosis. Possibly, however, some sium prophylactically with good success, patients may be incorrectly diagnosed-for although others have reported its failure to example, some psychiatric diagnosis as seen in prevent attacks." 12 Its success in our patients Denmark.' may be due to the milder form of the disease in Nine asymptomatic family members were Finland. Acetazolamide also seemed to sup- found who had abnormal results on the patho- press the paralytic attacks better than potas- logical potassium exercise test but no paralytic sium, although the patients who used acet- attacks.
Load more

Recommended publications
  • Neuromuscular Disorders Neurology in Practice: Series Editors: Robert A
    Neuromuscular Disorders neurology in practice: series editors: robert a. gross, department of neurology, university of rochester medical center, rochester, ny, usa jonathan w. mink, department of neurology, university of rochester medical center,rochester, ny, usa Neuromuscular Disorders edited by Rabi N. Tawil, MD Professor of Neurology University of Rochester Medical Center Rochester, NY, USA Shannon Venance, MD, PhD, FRCPCP Associate Professor of Neurology The University of Western Ontario London, Ontario, Canada A John Wiley & Sons, Ltd., Publication This edition fi rst published 2011, ® 2011 by Blackwell Publishing Ltd Blackwell Publishing was acquired by John Wiley & Sons in February 2007. Blackwell’s publishing program has been merged with Wiley’s global Scientifi c, Technical and Medical business to form Wiley-Blackwell. Registered offi ce: John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK Editorial offi ces: 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 111 River Street, Hoboken, NJ 07030-5774, USA For details of our global editorial offi ces, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell The right of the author to be identifi ed as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher.
    [Show full text]
  • THE NON-DYSTROPHIC MYOPATHIES JOHN PEARCE, M.B., M.R.C.P., Department of Neurology, the General Infirmary, Leeds
    Postgrad Med J: first published as 10.1136/pgmj.41.476.347 on 1 June 1965. Downloaded from POSTGRAD. MED. J. (1965), 41, 347 THE NON-DYSTROPHIC MYOPATHIES JOHN PEARCE, M.B., M.R.C.P., Department of Neurology, The General Infirmary, Leeds. THE TERM 'myopathy' is applied to any disorder Polymyositis may affect people of any age, of the muscle fibre, the muscle fibre membrane, but the age of onset is from 30 to 60 in 60% the myoneural junction, or the muscle connect- of cases. The chief symptom is weakness of ive tissue. 'Non-dystrophic myopathy' includes proximal muscles of the arms and/or legs all diseases of muscle excluding those genetically in every case. Distal muscles are affected in determined primary degenerative myopathies, one third, and the neck muscles in two thirds collectively known as Muscular Dystrophy. of patients. Fever, muscular pain and tenderness TABLE 1 are seen most often in the more acute forms, CLASSIFICATION OF NON-DYSTROPHIC MYOPATHIES and their absence should not lead to neglecting 1. Inflammatory Polymyositis as a Myopathy Connective tissue disorders polymyositis possible diagnosis. Other inflammatory mvopathies Acute polymyositis is not common, but may 2. Metabolic Familial periodic paralysis progress rapidly and involve the respiratory Myopathy Muscle glycogenoses muscles, sometimes with a fatal termination Myoglobinuric myopathies within a few weeks or months. Myopathies associated with Subacute and electrolyte imbalance chronic forms are more frequent, and present Unclassified myopathies with a progressive weakness and moderate of shoulder 3. Endocrine Thyrotoxicosis wasting and pelvic girdle muscles. Myopathy Cushing's Syndrome There is sometimes no systemic disturbance, Steroid myopathy and pain and tenderness are lacking.
    [Show full text]
  • Periodic Paralysis
    Periodic Paralysis In Focus Dear Readers Fast Facts This “In Focus” report is the third in a series of MDA’s three-year commitment for all Hypokalemic periodic paralysis MDA comprehensive reports about the latest in periodic paralysis research as of March Hypokalemic PP can begin anywhere from neuromuscular disease research and manage- 2009 is $1,938,367. The Association’s early childhood to the 30s, with periodic ment. allocation for research on hyperkalemic attacks of severe weakness lasting hours This report focuses on the periodic and hypokalemic periodic paralysis to days. The frequency of attacks gener- paralyses, a group of disorders that result from research since 1950 is $8,125,341. ally lessens in the 40s or 50s. Permanent malfunctions in so-called ion channels, micro- MDA’s allocation for the recently weakness may persist between attacks, scopic tunnels that make possible high-speed identified Andersen-Tawil syndrome usually beginning in middle age and pro- movement of electrically charged particles is $515,430 since 2001. MDA is cur- gressing slowly over years. across barriers inside cells and between cells rently funding 11 grants in the periodic The most common underlying cause and their surroundings. paralyses. is any of several genetic mutations in When ion channels fail to open or close The periodic paralyses are gener- a gene on chromosome 1 that carries according to an exquisitely fine-tuned program, ally divided into hyperkalemic periodic instructions for a calcium channel protein episodes of paralysis of the skeletal muscles paralysis, hypokalemic periodic paralysis in skeletal muscle fibers. When this chan- and even temporary irregularities in the heart- and Andersen-Tawil syndrome.
    [Show full text]
  • Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders
    diagnostics Review Facilitations and Hurdles of Genetic Testing in Neuromuscular Disorders Andrea Barp 1,*, Lorena Mosca 2 and Valeria Ada Sansone 1 1 The NEMO Clinical Center in Milan, Neurorehabilitation Unit, University of Milan, Piazza Ospedale Maggiore 3, 20162 Milano, Italy; [email protected] 2 Medical Genetics Unit, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162 Milano, Italy; [email protected] * Correspondence: [email protected] Abstract: Neuromuscular disorders (NMDs) comprise a heterogeneous group of disorders that affect about one in every thousand individuals worldwide. The vast majority of NMDs has a genetic cause, with about 600 genes already identified. Application of genetic testing in NMDs can be useful for several reasons: correct diagnostic definition of a proband, extensive familial counselling to identify subjects at risk, and prenatal diagnosis to prevent the recurrence of the disease; furthermore, identification of specific genetic mutations still remains mandatory in some cases for clinical trial enrollment where new gene therapies are now approaching. Even though genetic analysis is catching on in the neuromuscular field, pitfalls and hurdles still remain and they should be taken into account by clinicians, as for example the use of next generation sequencing (NGS) where many single nucleotide variants of “unknown significance” can emerge, complicating the correct interpretation of genotype-phenotype relationship. Finally, when all efforts in terms of molecular analysis have been carried on, a portion of patients affected by NMDs still remain “not genetically defined”. In the present review we analyze the evolution of genetic techniques, from Sanger sequencing to NGS, and we discuss “facilitations and hurdles” of genetic testing which must always be balanced by clinicians, Citation: Barp, A.; Mosca, L.; in order to ensure a correct diagnostic definition, but taking always into account the benefit that the Sansone, V.A.
    [Show full text]
  • Identification of Gene Mutations in Patients with Primary Periodic
    Luo et al. BMC Neurology (2019) 19:92 https://doi.org/10.1186/s12883-019-1322-6 RESEARCH ARTICLE Open Access Identification of gene mutations in patients with primary periodic paralysis using targeted next-generation sequencing Sushan Luo1†, Minjie Xu2†, Jian Sun1, Kai Qiao3, Jie Song1, Shuang Cai1, Wenhua Zhu1, Lei Zhou1, Jianying Xi1, Jiahong Lu1, Xiaohua Ni2, Tonghai Dou4 and Chongbo Zhao1,5* Abstract Background: Primary periodic paralysis is characterized by recurrent quadriplegia typically associated with abnormal serum potassium levels. The molecular diagnosis of primary PP previously based on Sanger sequencing of hot spots or exon-by-exon screening of the reported genes. Methods: We developed a gene panel that includes 10 ion channel-related genes and 245 muscular dystrophy- and myopathy-related genes and used this panel to diagnose 60 patients with primary periodic paralysis and identify the disease-causing or risk-associated gene mutations. Results: Mutations of 5 genes were discovered in 39 patients (65.0%). SCN4A, KCNJ2 and CACNA1S variants accounted for 92.5% of the patients with a genetic diagnosis. Conclusions: Targeted next-generation sequencing offers a cost-effective approach to expand the genotypes of primary periodic paralysis. A clearer genetic profile enables the prevention of paralysis attacks, avoidance of triggers and the monitoring of complications. Keywords: Primary periodic paralysis, Targeted next-generation sequencing, Gene panel, Gene mutation distribution, Calcium homeostasis. Background (SCN4A) and potassium voltage-gated channel subfamily Periodic paralysis (PP) is characterized by episodes of J member 2 (KCNJ2), that encode voltage-gated chan- muscle weakness that occur at irregular intervals due to nels in muscle membranes that generate or sustain skeletal muscle ion channelopathies.
    [Show full text]
  • Cerebral Hypotonia by Mihee Bay MD (Dr
    Cerebral hypotonia By Mihee Bay MD (Dr. Bay of Kennedy Krieger Institute and Johns Hopkins School of Medicine has no relevant financial relationships to disclose.) Originally released July 12, 2006; last updated February 1, 2016; expires February 1, 2019 Introduction This article includes discussion of cerebral hypotonia, central hypotonia, essential hypotonia, benign congenital hypotonia, and floppy infant. The foregoing terms may include synonyms, similar disorders, variations in usage, and abbreviations. Overview Hypotonia is a clinical manifestation of numerous diseases affecting the central and/or peripheral motor nervous system. The key to accurate diagnosis involves integral steps of evaluation that include a detailed history, examination, and diagnostic tests. “Cerebral” (or central) hypotonia implies pathogenesis from abnormalities from the central nervous system, and related causal disorders include cerebral dysgenesis and genetic or metabolic disorders. Patients with central hypotonia generally have hypotonia without associated weakness, in contrast to the peripheral (lower motor neuron) causes, which typically produce both hypotonia and muscle weakness. Hypotonia is a clinical manifestation of over 500 genetic disorders; thus, a logical, stepwise approach to diagnosis is essential. With recent advances in the field of genetic testing, diagnostic yield will undoubtedly improve. There is no cure, but treatment includes supportive therapies, such as physical and occupational therapy, and diagnosis-specific management. Key points • Hypotonia is reduced tension or resistance of passive range of motion. • The first step in the evaluation of a child with hypotonia is localization to the central (“cerebral”) or peripheral nervous system, or both. • Central hypotonia is more likely to be noted axially with normal strength and hyperactive to normal deep tendon reflexes.
    [Show full text]
  • Genetic Neuromuscular Disease *
    J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.73.suppl_2.ii12 on 1 December 2002. Downloaded from GENETIC NEUROMUSCULAR DISEASE Mary M Reilly, Michael G Hanna ii12* J Neurol Neurosurg Psychiatry 2002;73(Suppl II):ii12–ii21 he clinical practice of neuromuscular disease is currently undergoing enormous change as a direct result of the wealth of recent molecular genetic discoveries. Indeed, the majority of gene Tdiscoveries in the area of neurological disease relate to neuromuscular disorders. The immedi- ate impact of these discoveries is that a precise DNA based diagnosis is possible. This often gives patients accurate prognostic and genetic counselling information. It will also facilitate rational screening programmes for recognised complications such as cardiac or respiratory involvement. Unfortunately, at present many eligible patients do not benefit from or have access to such diagnostic precision, although this is changing. The discovery of new genes and proteins has opened up unexplored avenues of research into therapies for neuromuscular patients. While therapeutic trials in genetic neuromuscular diseases remain in their infancy, it seems clear that a precise DNA based diagnosis will be essential. Eligi- bility for such trials and indeed for future proven therapies will be contingent upon DNA based diagnosis. For example, it is no longer acceptable to make “limb-girdle muscular dystrophy” based on simple histochemistry, a final diagnosis. Detailed immunocytochemistry and protein chemistry in combination with DNA analysis offer the patient the best chance of a precise diagnosis from which accurate prognostication, screening, and genetic counselling will follow. In this review we describe some of the more common genetic nerve and muscle diseases encountered by adult neurologists.
    [Show full text]
  • Muscle Channelopathies
    Muscle Channelopathies Stanley Iyadurai, MSc PhD MD Assistant Professor of Neurology, Neuromuscular Specialist, OSU, Columbus, OH August 28, 2015 24 F 9 M 18 M 23 F 16 M 8/10 Occasional “Paralytic “Seizures at “Can’t Release Headaches Gait Problems Episodes” Night” Grip” Nausea Few Seconds Few Hours “Parasomnia” “Worse in Winter” Vomiting Debilitating Few Days Full Recovery Full Recovery Video EEG Exercise – Light- Worse Sound- 1-2x/month 1-2x/year Pelvic Red Lobster Thrusting 1-2x/day 3-4/year Dad? Dad? 1-2x/year Dad? Sister Normal Exam Normal Exam Normal Exam Normal Exam Hyporeflexia Normal Exam “Defined Muscles” Photophobia Hyper-reflexia Phonophobia Migraines Episodic Ataxia Hypo Per Paralysis ADNFLE PMC CHANNELOPATHIES DEFINITION Channelopathy: a disease caused by dysfunction of ion channels; either inherited (Mendelian) or acquired/complex (Non-Mendelian, e.g., autoimmune), presenting either in neurologic or non-neurologic fashion CHANNELOPATHY SPECTRUM CHARACTERISTICS Paroxysmal Episodic Intermittent/Fluctuating Bouts/Attacks Between Attacks Patients are Usually Completely Normal Triggers – Hunger, Fatigue, Emotions, Stress, Exercise, Diet, Temperature, or Hormones Muscle Myotonic Disorders Periodic Paralysis MUSCLE CHANNELOPATHIES Malignant Hyperthermia CNS Migraine Episodic Ataxia Generalized Epilepsy with Febrile Seizures Plus Hereditary & Peripheral nerve Acquired Erythromelalgia Congenital Insensitivity to Pain Neuromyotonia NMJ Congenital Myasthenic Syndromes Myasthenia Gravis Lambert-Eaton MS Cardiac Congenital
    [Show full text]
  • Primary Hypokalemic Periodic Paralysis Showed an Induration of 20 Mm
    BRIEF REPORTS Primary Hypokalemic Periodic 3-4 days every time. Most of the episodes Paralysis started in the early morning hours without any particular precipitating factor. The patient used to have 3-4 such episodes every year. One of the attacks also involved res- piratory muscles. The general examination V.P. Dandge was normal except for the presence of W.B. Pagarkar bilateral phlyctenular conjunctivitis. There M. Agarwal was hypotonia and proximal muscle weak- V.R. Dharnidharka ness in the limbs except right upper limb S.P. Rathi which was normal. Deep tendon jerks were depressed with bilateral flexor planters. No other neurological signs were present. On investigations, the tuberuclin test Primary hypokalemic periodic paralysis showed an induration of 20 mm. As shown (PHPP) is a rare entity first described by in Table I, the patient had a consistent Shakanowitch in 1882. Only a few cases of hypokalemia in the first week of hospitali- PHPP have been reported in Indian litera- zation along with ECG showing prominent ture in adults(l). In children hypokalemic 'U' waves till the fifth day. Initial arterial paralysis secondary to gastroenteritis and blood pH was normal. Other related inves- chronic renal disease is much more com- tigations were normal. mon than primary disease(2). We hereby report a case of PHPP in a child, success- Considering the clinical pattern and fully managed with acetazolamide and oral biochemical abnormalities, a diagnosis of potassium supplementation. primary hypokalemic periodic paralysis was made and the patient was put on oral Case Report potassium supplements and acetazolamide An 11-year-old boy weighing 15 kg (30 mg/kg/day) from the second day of presented with complaints of recurrent hospitalization.
    [Show full text]
  • The Nondystrophic Myotonias
    Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics The Nondystrophic Myotonias Chad R. Heatwole* and Richard T. Moxley III*† *Department of Neurology and †Department of Pediatrics, University of Rochester, Rochester, New York Summary: The nondystrophic myotonias are a heterogeneous (paramyotonia congenita, potassium-aggravated myotonia, set of rare diseases that demonstrate clinical myotonia, electri- and hyperkalemic periodic paralysis with myotonia). The cal myotonia, or both. These disorders are distinguished from variants that occur in each of these conditions are com- myotonic dystrophy type 1 (DM-1), the more recently de- mented on. The differentiating features of the nondystrophic scribed proximal myotonic myopathy/myotonic dystrophy type myotonias are summarized, and their predominant clinical, 2 (PROMM/DM-2), and proximal myotonic dystrophy (a vari- electrodiagnostic, and genetic characteristics are tabulated. ant of DM-2) by characteristic clinical features, lack of abnor- For a comprehensive review of pertinent research and stud- mal nucleotide repeat expansions in the DM-1 and DM-2 ies with application to diagnosis and treatment of individuals genes, lack of cataracts and endocrine disturbances, and ab- with nondystrophic myotonic disorders, the present article is sence of significant histopathology in the muscle biopsy. The best read in the context of other articles in this issue, espe- present article reviews each of the nondystrophic myotonias cially those on ion channel physiology (Cannon)
    [Show full text]
  • Transient Compartment-Like Syndrome and Normokalaemic Periodic Paralysis Due to a Cav1.1 Mutation
    doi:10.1093/brain/awt300 Brain 2013: 136; 3775–3786 | 3775 BRAIN A JOURNAL OF NEUROLOGY Transient compartment-like syndrome and normokalaemic periodic paralysis due to a Cav1.1 mutation Downloaded from https://academic.oup.com/brain/article/136/12/3775/447564 by guest on 01 October 2021 Chunxiang Fan,1 Frank Lehmann-Horn,1,2 Marc-Andre´ Weber,3,4 Marcin Bednarz,1 James R. Groome,5 Malin K. B. Jonsson6 and Karin Jurkat-Rott1,2 1 Neurophysiology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany 2 Rare Disease Centre (ZSE) Ulm and Neuromuscular Disease Centre (NMZ) Ulm, Germany 3 University Hospital of Heidelberg, Department of Diagnostic and Interventional Radiology, Heidelberg, Germany 4 Department of Radiology, German Cancer Research Centre, Heidelberg, Germany 5 Biology Department, Idaho State University, Pocatello, ID, USA 6 Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands Correspondence to: Karin Jurkat-Rott, Division of Neurophysiology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany E-mail: [email protected] We studied a two-generation family presenting with conditions that included progressive permanent weakness, myopathic myopathy, exercise-induced contracture before normokalaemic periodic paralysis or, if localized to the tibial anterior muscle group, transient compartment-like syndrome (painful acute oedema with neuronal compression and drop foot). 23Na and 1H magnetic resonance imaging displayed myoplasmic sodium overload, and oedema. We identified a novel familial Cav1.1 calcium channel mutation, R1242G, localized to the third positive charge of the domain IV voltage sensor. Functional expression of R1242G in the muscular dysgenesis mouse cell line GLT revealed a 28% reduced central pore inward current and a À20 mV shift of the steady-state inactivation curve.
    [Show full text]
  • PDF File for Your Own Personal Use
    I am pleased to provide you complimentary one-time access to my article as a PDF file for your own personal use. Any further/multiple distribution, publication or commercial usage of this copyrighted material would require submission of a permission request to the publisher. Timothy M. Miller, MD, PhD Correlating phenotype and genotype in the periodic paralyses T.M. Miller, MD, PhD; M.R. Dias da Silva, MD, PhD; H.A. Miller, BS; H. Kwiecinski, MD, PhD; J.R. Mendell, MD; R. Tawil, MD; P. McManis, MD; R.C. Griggs, MD; C. Angelini, MD; S. Servidei, MD; J. Petajan, MD, PhD; M.C. Dalakas, MD; L.P.W. Ranum, PhD; Y.H. Fu, PhD; and L.J. Ptáek, MD Abstract—Background: Periodic paralyses and paramyotonia congenita are rare disorders causing disabling weakness and myotonia. Mutations in sodium, calcium, and potassium channels have been recognized as causing disease. Objective: To analyze the clinical phenotype of patients with and without discernible genotype and to identify other mutations in ion channel genes associated with disease. Methods: The authors have reviewed clinical data in patients with a diagnosis of hypokalemic periodic paralysis (56 kindreds, 71 patients), hyperkalemic periodic paralysis (47 kindreds, 99 patients), and paramyotonia congenita (24 kindreds, 56 patients). For those patients without one of the classically known mutations, the authors analyzed the entire coding region of the SCN4A, KCNE3, and KCNJ2 genes and portions of the coding region of the CACNA1S gene in order to identify new mutations. Results: Mutations were identified in approximately two thirds of kindreds with periodic paralysis or paramyotonia congenita.
    [Show full text]